Dec 29, 2020 12:20 PM IST
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 520 in its research report dated December 28, 2020.
- Dec 29, 2020 09:47 AM IST
The share touched its 52-week high Rs 487.70 and 52-week low Rs 235.80 on 23 December, 2020 and 19 March, 2020, respectively.
- Dec 28, 2020 10:19 AM IST
Biocon Biologics, and Mylan have been informed by the US health regulator of deferred action on the biologics licence application for a biosimilar to drug Avastin, used to treat various types of cancers, Biocon said.
- Dec 18, 2020 03:24 PM IST
Avani, daughter of SpiceJet Chairman & MD Ajay Singh, is the CEO of SpiceHealth
- Dec 03, 2020 05:46 PM IST
With a net worth of Rs 54,850 crore, HCL Technologies Chairperson Roshni Nadar Malhotra is India's richest women in 2020, according to a study by Kotak Wealth and Hurun India. Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore, followed by Leena Gandhi Tewari, Chairperson of USV (Rs 21,340 crore). The cumulative wealth of the 100 women on the list is Rs 2.73 lakh crore, the study said. Here are India's richest women in 2020, as per the Kotak Wealth Hurun list:
- Dec 03, 2020 03:36 PM IST
Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore
- Dec 03, 2020 01:23 PM IST
To attain self-reliance, Indian companies still need to harness innovation through international partnerships and collaborations, Kiran Mazumdar-Shaw has said.
- Dec 02, 2020 09:45 AM IST
Efforts to diversify will open up new opportunities for Laurus Labs and make it move towards a higher-margin trajectory
- Nov 24, 2020 12:21 PM IST
If the negotiations fructify— coming two weeks after the Goldman Sachs deal—it would mark the fourth successive investment in the Kiran Mazumdar Shaw-led Biocon unit in 2020.The last fundraise was struck at a valuation of $3.94 billion.
- Nov 21, 2020 04:06 PM IST
ZS PRIZE is open to students and professionals from the start-up, enterprise, and NGO sectors of India. Indian citizens above the age of 18 can submit their ideas or solution prototypes till December 21, 2020
- Nov 07, 2020 04:04 PM IST
As per the terms of the proposed agreement, Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion. The transaction is subject to customary approvals and conditions
- Oct 27, 2020 06:58 PM IST
Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 400 in its research report dated October 23, 2020.
- Oct 27, 2020 04:02 PM IST
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 495 in its research report dated October 23, 2020.
- Oct 27, 2020 02:11 PM IST
ICICI Direct is bullish on Biocon recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 23, 2020.
- Oct 27, 2020 09:41 AM IST
- Oct 27, 2020 09:33 AM IST
- Oct 26, 2020 08:25 PM IST
- Oct 26, 2020 08:13 PM IST
- Oct 24, 2020 01:41 PM IST
Shaw says vaccine candidates will first be approved for emergency use and full approval will come only after evaluating the durability of response.
- Oct 23, 2020 07:14 PM IST
The employee, Vandana Singh (noticee), general manager regulatory affair of Biocon at the time of investigation and also a designated person, is facing a fine of Rs 3 lakh for violating provisions of Prohibition of Insider Trading (PIT) norms.
- Oct 23, 2020 01:51 PM IST
It had posted a net profit of Rs 253.8 crore for the July-September quarter previous fiscal, Biocon said in a late-night BSE filing on Thursday.
- Oct 01, 2020 09:29 PM IST
If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics
- Sep 25, 2020 09:39 AM IST
Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.
- Sep 01, 2020 11:13 AM IST
As per a regulatory filing on BSE, Biocon Biologics India, a subsidiary of Biocon, and Mylan N.V., announced the US launch of Semglee.
- Aug 19, 2020 08:28 AM IST
Technically we believe the index is expected to swing above the upper bound of the 'Broadening formation (11,377)' & move towards 11,500 zone swiftly.